By Mike Metzger
Antibiotics are used widely to fight bacterial infections in humans and animals. However, if the bacteria develop a resistance to that antibiotic, the drug becomes less effective in fighting the infections. For this reason, over the counter (OTC) antibiotics will only be available to producers from a veterinarian or with a prescription from a veterinarian.
To ensure continued effective use in humans and animals the US Food and Drug Administration Center for Veterinary Medicine has developed a 5-year Veterinary Stewardship Plan designed to slow the emergence of antimicrobial resistance that can arise from the misuse of antibiotics in animals while ensuring safe and effective use of medically important antibiotics in animals and humans. Many antibiotics are medically important to both human and animal health. The intent of this legislation is to ensure that these drugs are used under veterinary supervision, reducing the chance for development of antimicrobial resistance to these drugs in both humans and animals.
In 2017, FDA placed in-feed and water-soluble medications use under veterinarian supervision through Veterinary Feed Directive. The next steps in this transition will move OTC products to veterinary oversight. As of June 11, 2023, all medically important antibiotics in dosage forms such as injectable, intramammary and boluses, approved for use in animals — both food-producing and companion — will no longer be available over the counter. The drugs will also display the following statement on the label “Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian”. Products sold OTC, are typically sold at farm stores, feed stores and by on-line suppliers.